Devdiscourse

Booming Weight-Loss Market and Legal Battles in Health News

The health sector witnesses significant developments with Eli Lilly's promising weight-loss drug trials and a $40 million ...
Everyday Health on MSN

Quitting Zepbound Leads to at Least 25 Percent Weight Regain After a Year

Most people who stopped taking their weight loss injections also experienced negative changes in blood pressure, waist size, and other health metrics.
WRIC ABC 8News on MSN

Never skip taking weight-loss medications, even during holiday season and health coverage changes: UVA Health

With foodborne illnesses and changes in Medicare and Medicaid coverage, University of Virginia (UVA) Health experts say never ...

Target beefs up protein, supplement offerings, capitalizing on weight loss drug trend

Target has expanded its protein and supplement sections as GLP-1 drugs like Ozempic reshape shopping habits, driving demand ...

Eli Lilly's Stock Drops as It Slashes the Price of Zepbound: Time to Buy the Dip?

Eli Lilly's decision to reduce the price of its popular weight loss drug makes more sense than it appears at first. The ...

Weight-loss drugs fill a treatment gap for women with hormone disorder PCOS, doctors say

Women with polycystic ovary syndrome are increasingly turning to blockbuster weight-loss drugs from Eli Lilly and Novo ...